Paul Davis
Principal investigator, leads NANOPHARMACEUTICALS, LLC.
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2024First federal award
$1.7MFederal grants as PI2 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
2 awards · $1.7M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 10, 2025 | NIH | SBIR Phase II NP855 for Targeting Thyrointegrin αvβ3 receptors and Norepinephrine Transporter in Neuroblastoma Management | $869K | NANOPHARMACEUTICALS, LLC |
| Sep 19, 2024 | NIH | SBIR Phase II NP855 for Targeting Thyrointegrin αvβ3 receptors and Norepinephrine Transporter in Neuroblastoma Management | $792K | NANOPHARMACEUTICALS, LLC |
1 patents as inventor
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#1,264
Awards as PI#1,252
Patents#273
Companies
- NANOPHARMACEUTICALS, LLCLeads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.